Oncotarget

Research Papers:

AM1241 alleviates MPTP-induced Parkinson's disease and promotes the regeneration of DA neurons in PD mice

Jun Shi, Qiong Cai, Jingxing Zhang, Xiaolie He, Yigang Liu, Rongrong Zhu _ and Lingjing Jin

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:67837-67850. https://doi.org/10.18632/oncotarget.18871

Metrics: PDF 821 views  |   HTML 2199 views  |   ?  


Abstract

Jun Shi1,2,*, Qiong Cai1,*, Jingxing Zhang1, Xiaolie He1, Yigang Liu1, Rongrong Zhu1,3 and Lingjing Jin1

1Department of Neurology, Tongji Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200065, China

2College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China

3School of Life Science and Technology, Tongji University, Shanghai 200092, China

*These authors have contributed equally to this work

Correspondence to:

Rongrong Zhu, email: rrzhu@tongji.edu.cn

Lingjing Jin, email: lingjingjin@163.com

Keywords: AM1241, PD, MPTP, PI3K/AKT, neurogenesis

Received: October 31, 2016    Accepted: June 01, 2017    Published: June 29, 2017

ABSTRACT

The main pathological feature of Parkinson’s disease (PD) is the loss of dopaminergic neurons in the substantia nigra. In this study, we investigated the role of cannabinoid receptor 2 (CB2R) agonist AM1241 on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in a mouse model of PD. Upon treatment with AM1241, the decreased CB2R level in the PD mouse brain was reversed and the behavior score markedly elevated, accompanied with a dose-dependent increase of dopamine and serotonin. In addition, western blot assay and immunostaining results suggested that AM1241 significantly activated PI3K/Akt/MEK phosphorylation and increased the expression of Parkin and PINK1, both in the substantia nigra and hippocampus. The mRNA expression analysis further demonstrated that AM1241 increased expression of the CB2R and activated Parkin/PINK1 signaling pathways. Furthermore, the increased number of TH-positive cells in the substantia nigra indicated that AM1241 regenerated DA neurons in PD mice, and could therefore be a potential candidate for PD treatment. The clear co-localization of CB2R and DA neurons suggested that AM1241 targeted CB2R, thus also identifying a novel target for PD treatment. In conclusion, the selective CB2 agonist AM1241 has a significant therapeutic effect on PD mice and resulted in regeneration of DA neurons following MPTP-induced neurotoxicity. The possible mechanisms underlying the neurogenesis effect of AM1241 might be the induction of CB2R expression and an increase in phosphorylation of the PI3K/AKT signaling pathway.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 18871